Introducing Ben Kotopka, Director of Data Science
Ben’s work enables teams across the business to track and make sense of more than a decade of R&D data.
Introducing Pavel Aronov, Senior Director, Bioanalytics
Pavel and his team have developed the processes to accurately measure the quantity of our biosynthetic KSMs and APIs produced via biomanufacturing, which is no small feat when working with biological products
“What’s Your Problem?” Podcast: Getting Yeast to Make Medicine
Antheia is a synthetic biology company in the business of genetically engineering microorganisms to produce commercial products.
First Demonstration of Neuro Therapeutic Tropane Alkaloids Produced in Yeast
Researchers report the first successful microbial biosynthesis of the tropane alkaloids hyoscyamine and scopolamine, a class of neuromuscular blockers naturally found in plants in the nightshade family…
New paper demonstrates most advanced example of engineering integrated systems for biosynthesis
A new paper published today in the journal Nature describes the first successful microbial biosynthesis of the tropane alkaloids hyoscyamine and scopolamine, a class of neuromuscular blockers naturally found in plants in the nightshade family…
Engineered Yeast Produce Hyoscyamine and Scopolamine
Successful production of medicinal compounds from plants depends on weather and growing seasons, potentially making supply chains vulnerable to uncontrollable forces. One way around such challenges is to use microorganisms as factories to make the compounds instead…
Revealed: A Clearer View of How General Anaesthetics Actually Work
You may never have heard of tropane alkaloids, but they are classed as essential medicines by the World Health Organization, for good reason since they are used in the treatment of a wide range of conditions, as synthetic biologist Christina Smolke explains…
A Milestone for Drug Manufacturing and Synthetic Biology: Stanford Research Published in Nature
It’s a momentous day for my research team at Stanford University. Today, we’ve announced a new paper published in Nature that describes the first successful microbial biosynthesis of the tropane alkaloids hyoscyamine and scopolamine…
Stanford Team Turns Lowly Yeast into Medicine, and So Much More
For millenniums, humans have harnessed yeast to brew beer. Now, in the latest advance in the fast-moving field of “synthetic biology,” a Stanford team is enlisting the lowly fungus to do so much more…
Antheia Receives Phase I SBIR Award from the National Institute of Drug Abuse to Make Non-Addict…
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for the nal opioids naloxone and naltrexone through whole cell biocatalysis…